In search of a function for the most frequent naturally-occurring length polymorphism (MFNLP) of the HIV-1 LTR: Retaining functional coupling, of Nef and RBF-2, at RBEIII?

International Journal of Biological Sciences

Volumn 3, Issue 5, 2007, Pages 318-327

  Estable, Mario Clemente ^a  

^a RYERSON UNIVERSITY   (Canada)

Author keywords

HIV 1 polymorphisms; MFNLP

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NEF PROTEIN; PROTEIN; RBF 2 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR;

BINDING SITE; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MOST FREQUENT NATURALLY OCCURRING LENGTH POLYMORPHISM; NONHUMAN; PROTEIN BINDING; REVERSE TRANSCRIPTION; REVIEW; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIRUS ACTIVATION; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34250714960     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3.318     Document Type: Review

References (76)

1. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, and Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868-871
2. Wattel E, Vartanian JP, Pannetier C, and Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995; 69: 2863-2868
3. Gessain A, Gallo RC, and Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 1992; 66: 2288-2295
4. Wain-Hobson S. Running the gamut of retroviral variation. Trends Microbiol 1996; 4: 135-141
5. Komurian F, Pelloquin F, and de The G. In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 1991; 65: 3770-3778
6. Kunkel TA. DNA replication fidelity. J Biol Chem 1992; 267: 18251-18254
7. Preston BD, and Dougherty JP. Mechanisms of retroviral mutation. Trends Microbiol 1996; 4: 16-21
8. Zenkin N, Yuzenkova Y, and Severinov K. Transcript-assisted transcriptional proofreading. Science 2006; 313: 518-520
9. Freed EO. HIV-1 replication. Somat Cell Mol Genet 2001; 26: 13-33
10. Rausch JW, and Le Grice SF. 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol 2004; 36: 1752-1766
11. Cheynier R, Gratton S, Vartanian JP, Meyerhans A, and Wain-Hobson S. G -> A hypermutation does not result from polymerase chain reaction. AIDS Res Hum Retroviruses 1997; 13: 985-986
12. Meyerhans A, Vartanian JP, Hultgren C, Plikat U, Karlsson A, Wang L, Eriksson S, and Wain-Hobson S. Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol 1994; 68: 535-540
13. Vartanian JP, Plikat U, Henry M, Mahieux R, Guillemot L, Meyerhans A, and Wain-Hobson S. HIV genetic variation is directed and restricted by DNA precursor availability. J Mol Biol 1997; 270: 139-151
14. Vartanian JP, Meyerhans A, Sala M, and Wain-Hobson S. G -> A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc Natl Acad Sci U S A 1994; 91: 3092-3096
15. Delassus S, Cheynier R, and Wain-Hobson S. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol 1991; 65: 225-231
16. Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, and Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr 1989; 2: 344-352
17. Vartanian JP, Meyerhans A, Asjo B, and Wain-Hobson S. Selection, recombination, and G - A hypermutation of human immunodeficiency virus type 1 genomes. J Virol 1991; 65: 1779-1788
18. Skalka A, and Goff S. Reverse Transcriptase. New York: Cold Spring Harbor Press. 1993
19. Vartanian JP, Sommer P, and Wain-Hobson S. Death and the retrovirus. Trends Mol Med 2003; 9: 409-413
20. Suspene R, Rusniok C, Vartanian JP, and Wain-Hobson S. Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication. Nucleic Acids Res 2006; 34: 4677-4684
21. Simon V, Zennou V, Murray D, Huang Y, Ho DD, and Bieniasz PD. Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification. PLoS Pathog 2005; 1: e6
22. Patel PH, and Preston BD. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc Natl Acad Sci U S A 1994; 91: 549-553
23. Allain B, Lapadat-Tapolsky M, Berlioz C, and Darlix JL. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. Embo J 1994; 13: 973-981
24. Darlix JL, Vincent A, Gabus C, de Rocquigny H, and Roques B. Trans-activation of the 5′ to 3′ viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV1 RNA. C R Acad Sci III 1993; 316: 763-771
25. Guo J, Henderson LE, Bess J, Kane B, and Levin JG. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J Virol 1997; 71: 5178-5188
26. Klaver B, and Berkhout B. Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J Virol 1994; 68: 3830-3840
27. Ramsey CA, and Panganiban AT. Replication of the retroviral terminal repeat sequence during in vivo reverse transcription. J Virol 1993; 67: 4114-4121
28. Temin HM. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci U S A 1993; 90: 6900-6903
29. Panganiban AT, and Fiore D. Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 1988; 241: 1064-1069
30. Jones JS, Allan RW, and Temin HM. One retroviral RNA is sufficient for synthesis of viral DNA. J Virol 1994; 68: 207-216
31. Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, and Sharp PM. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996; 70: 7013-7029
32. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, Fischer U, Meese E, Wain-Hobson S, and Meyerhans A. Multiply infected spleen cells in HIV patients. Nature 2002; 418: 144
33. Meyerhans A, Jung A, Maier R, Vartanian JP, Bocharov G, and Wain-Hobson S. The non-clonal and transitory nature of HIV in vivo. Swiss Med Wkly 2003; 133: 451-454
34. Nethe M, Berkhout B, and van der Kuyl AC. Retroviral superinfection resistance. Retrovirology 2005; 2: 52
35. Preston BD. Error-prone retrotransposition: rime of the ancient mutators. Proc Natl Acad Sci U S A 1996; 93: 7427-7431
36. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995; 267: 483-489
37. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-126
38. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al.. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122
39. Biebricher CK, and Eigen M. What is a quasispecies? Curr Top Microbiol Immunol 2006; 299: 1-31
40. Wain-Hobson S, Sonigo P, Danos O, Cole S, and Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell 1985; 40: 9-17
41. Pereira LA, Bentley K, Peeters A, Churchill MJ, and Deacon NJ. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 2000; 28: 663-668
42. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, and Sadowski IJ. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996; 70: 4053-4062
43. Golub E, Li G, and Volsky D. Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol. 1991; 64: 3654-3660
44. Blumberg BM, Epstein LG, Saito Y, Chen D, Sharer LR, and Anand R. Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J Virol 1992; 66: 5256-5264
45. Koken SE, van Wamel JL, Goudsmit J, Berkhout B, and Geelen JL. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 1992; 191: 968-972
46. Koken SE, van Wamel JL, Geelen JL, and Berkhout B. Functional Analysis of the ACTGCTGA Sequence Motif in the Human Immunodeficiency Virus Type-1 Long Terminal Repeat Promoter. J Biomed Sci 1994; 1: 83-92
47. Michael NL, D'Arcy L, Ehrenberg PK, and Redfield RR. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol 1994; 68: 3163-3174
48. Ait-Khaled M, McLaughlin JE, Johnson MA, and Emery VC. Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. Aids 1995; 9: 675-683
49. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, and Ho DD. Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sites. J Virol 1997; 71: 1651-1656
50. Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, and Desrosiers RC. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 1997; 232: 319-331
51. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, and Ho DD. Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1997; 71: 5608-5613
52. Salvi R, Garbuglia AR, Di Caro A, Pulciani S, Montella F, and Benedetto A. Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol 1998; 72: 3646-3657
53. Quinones-Mateu ME, Mas A, Lain de Lera T, Soriano V, Alcami J, Lederman MM, and Domingo E. LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 1998; 57: 11-20
54. Estable MC, Merzouki A, Arella M, and Sadowski IJ. Distinct clustering of HIV type 1 sequences derived from injection versus noninjection drug users in Vancouver, Canada. AIDS Res Hum Retroviruses 1998; 14: 917-919
55. Naghavi MH, Schwartz S, Sonnerborg A, and Vahlne A. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res Hum Retroviruses 1999; 15: 1293-1303
56. Gomez-Roman VR, Vazquez JA, et al. nef/long terminal repeat quasispecies from HIV type 1-infected Mexican patients with different progression patterns and their pathogenesis in hu-PBL-SCID mice. AIDS Res Hum Retroviruses 2000; 16: 441-452
57. Chen P, Flory E, Avots A, Jordan BW, Kirchhoff F, Ludwig S, and Rapp UR. Transactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway. The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factors. J Biol Chem 2000; 275: 20382-20390
58. Birch MR, Learmont JC, Dyer WB, Deacon NJ, Zaunders JJ, Saksena N, Cunningham AL, Mills J, and Sullivan JS. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol 2001; 22: 263-270
59. Hiebenthal-Millow K, and Kirchhoff F. The most frequent naturally occurring length polymorphism in the HIV-1 LTR has little effect on proviral transcription and viral replication. Virology 2002; 292: 169-175
60. Kondo M, Shima T, Nishizawa M, Sudo K, Iwamuro S, Okabe T, Takebe Y, and Imai M. Identification of attenuated variants of HIV-1 circulating recombinant form 01_AE that are associated with slow disease progression due to gross genetic alterations in the nef/long terminal repeat sequences. J Infect Dis 2005; 192: 56-61
61. Nakanishi Y, Masamune Y, and Kobayashi N. A novel cis-acting element that controls transcription of human immunodeficiency virus type 1 DNA, depending on cell type. J Virol 1991; 65: 6334-6338
62. Zeichner SL, Kim JY, and Alwine JC. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J Virol 1991; 65: 2436-2444
63. Kim JY, Gonzalez-Scarano F, Zeichner SL, and Alwine JC. Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J Virol 1993; 67: 1658-1662
64. Bell B, and Sadowski I. Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites. Oncogene 1996; 13: 2687-2697
65. Estable MC, Bell B, Hirst M, and Sadowski I. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J Virol 1998; 72: 6465-6474
66. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, and Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000; 74: 3740-3751
67. Estable MC, Hirst M, Bell B, O'Shaughnessy MV, and Sadowski I. Purification of RBF-2, a transcription factor with specificity for the most conserved cis-element of naturally occurring HIV-1 LTRs. J Biomed Sci 1999; 6: 320-332
68. Bendall AJ, and Molloy PL. Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res 1994; 22: 2801-2810
69. Naghavi MH, Estable MC, Schwartz S, Roeder RG, and Vahlne A. Upstream stimulating factor affects human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in a cell-specific manner, independently of the HIV-1 subtype and the core-negative regulatory element. J Gen Virol 2001; 82: 547-559
70. Chen J, Malcolm T, Estable MC, Roeder RG, and Sadowski I. TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF. J Virol 2005; 79: 4396-4406
71. Sadowski I, and Mitchell DA. TFII-I and USF (RBF-2) regulate Ras/MAPK-responsive HIV-1 transcription in T cells. Eur J Cancer 2005; 41: 2528-2536
72. Churchill MJ, Rhodes DI, Learmont JC, Sullivan JS, Wesselingh SL, Cooke IR, Deacon NJ, and Gorry PR. Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source. J Virol 2006; 80: 1047-1052
73. Schrager JA, Der Minassian V, and Marsh JW. HIV Nef increases T cell ERK MAP kinase activity. J Biol Chem 2002; 277: 6137-6142
74. Schrager JA, and Marsh JW. HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A 1999; 96: 8167-8172
75. Niedzielski MF, Hopewell R, Ismail Z, and Estable MC. MCEF is localized to the nucleus by protein sequences encoded within three distinct exons, where it represses HIV-1 Tat-transactivation of LTR-directed transcription. Int J Biol Sci 2007; 3: 225-236
76. Estable MC, Naghavi MH, Kato H, Xiao H, Qin J, Vahlne A, and Roeder RG. MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein. J Biomed Sci 2002; 9: 234-245